Literature DB >> 25381833

Innovative models for the empowerment of patients with type 2 diabetes: the CAIPaDi program.

Sergio Hernandez-Jimenez, Cristina Garcia-Ulloa, Roopa Mehta, Carlos A Aguilar-Salinas, David Kershenobich-Stalnikowitz1.   

Abstract

Empowerment interventions for chronic diseases are an evolving process. No agreement exists regarding the necessary components and methodologies to be applied. Systematic reviews have assessed the effect of self-management interventions. Improvements in illness beliefs, adherence to drug therapy and glucose monitoring have been reported. In the long term, no major changes have been achieved in weight, physical activity, smoking status, and depression scores. There is a need for additional studies. The CAIPaDi (Centro de Atención Integral del Paciente con Diabetes) program is an intervention designed to provide education and empowerment techniques (using simple low-cost interactive tools) over a short period of time followed by at-distance support using internet or cell phone technology. The target population consists of patients with type 2 diabetes, free of chronic complications who are non-smokers. The intervention is composed of four monthly visits followed by a continuous at-distance support system. At each visit, patients stay for six hours in the center. Information is presented in group sessions. Empowerment techniques are applied during individual exchanges with the team or during facilitated group sessions. In summary, empowerment programs are an unmet need in many healthcare services. This review also discusses relevant studies and patents in the management of type 2 diabetes.

Entities:  

Mesh:

Year:  2014        PMID: 25381833     DOI: 10.2174/1872214808999141110155515

Source DB:  PubMed          Journal:  Recent Pat Endocr Metab Immune Drug Discov        ISSN: 1872-2148


  9 in total

1.  Design of a cluster-randomized trial of the effectiveness and cost-effectiveness of metformin on prevention of type 2 diabetes among prediabetic Mexican adults (the PRuDENTE initiative of Mexico City).

Authors:  Luis A Rodríguez; Simón Barquera; Carlos A Aguilar-Salinas; Jaime Sepúlveda-Amor; Luz María Sánchez-Romero; Edgar Denova-Gutiérrez; Nydia Balderas; Lizbeth Moreno-Loaeza; Margaret A Handley; Sanjay Basu; Oliva López-Arellano; Alberto Gallardo-Hernández; Dean Schillinger
Journal:  Contemp Clin Trials       Date:  2020-06-21       Impact factor: 2.226

Review 2.  Collaborative research and actions on both sides of the US-Mexico border to counteract type 2 diabetes in people of Mexican origin.

Authors:  Simón Barquera; Dean Schillinger; Carlos A Aguilar-Salinas; Marc Schenker; Luis A Rodríguez; Cesar Hernández-Alcaraz; Jaime Sepúlveda-Amor
Journal:  Global Health       Date:  2018-08-22       Impact factor: 4.185

3.  Translation and cross-cultural adaptation of the Behavior Change Protocol for educational practices in Diabetes Mellitus.

Authors:  Fernanda Azeredo Chaves; Sumaya Giarola Cecilio; Ilka Afonso Reis; Adriana Silvina Pagano; Heloísa de Carvalho Torres
Journal:  Rev Lat Am Enfermagem       Date:  2019-08-19

4.  Clinician prescription of lipid-lowering drugs and achievement of treatment goals in patients with newly diagnosed type 2 diabetes mellitus.

Authors:  Ana Cristina García-Ulloa; Claudia Lechuga-Fonseca; Fabiola Mabel Del Razo-Olvera; Carlos Alberto Aguilar-Salinas; Karla Ivette Galaviz; K M Venkat Narayan; Sergio Hernández-Jiménez
Journal:  BMJ Open Diabetes Res Care       Date:  2021-02

5.  Feasibility and acceptance of a virtual multidisciplinary care programme for patients with type 2 diabetes during the COVID-19 pandemic.

Authors:  Sergio Hernández-Jiménez; Ana Cristina García-Ulloa; María Teresa Alcántara-Garcés; Luz Elena Urbina-Arronte; Carolina Lara-Sánchez; Héctor Rafael Velázquez-Jurado
Journal:  Ther Adv Endocrinol Metab       Date:  2021-11-24       Impact factor: 3.565

6.  Comorbidity Between Recent Diagnosis of Type 2 Diabetes and Non-Psychotic Psychiatric Disorders: Metabolic Characteristics and Clinical Correlates.

Authors:  María Teresa Alcántara-Garcés; Alejandra Monserrat Rodríguez-Ramírez; Ana Cristina García-Ulloa; Sergio Hernández-Jiménez
Journal:  Neuropsychiatr Dis Treat       Date:  2022-06-12       Impact factor: 2.989

7.  Maintenance of Self-Care Activities During COVID-19 Lockdown in Patients with Type 2 Diabetes That Received a Comprehensive Care Program Training.

Authors:  Ana C García Ulloa; Maria S Tron-Gómez; Michelle Díaz-Pineda; Diana Hernández-Juárez; María V Landa-Anell; Marco A Melgarejo-Hernández; Sergio Hernández-Jiménez
Journal:  Diabetes Metab Syndr Obes       Date:  2022-09-19       Impact factor: 3.249

8.  Empowerment of patients with type 2 diabetes: current perspectives.

Authors:  Donají V Gómez-Velasco; Paloma Almeda-Valdes; Alexandro J Martagón; Gabriela A Galán-Ramírez; Carlos A Aguilar-Salinas
Journal:  Diabetes Metab Syndr Obes       Date:  2019-08-06       Impact factor: 3.168

9.  Prevalence and associated risk factors of diabetic retinopathy and macular oedema in patients recently diagnosed with type 2 diabetes.

Authors:  Enrique O Graue-Hernandez; David Rivera-De-La-Parra; Sergio Hernandez-Jimenez; Carlos A Aguilar-Salinas; David Kershenobich-Stalnikowitz; Aida Jimenez-Corona
Journal:  BMJ Open Ophthalmol       Date:  2020-03-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.